These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19572134)

  • 1. [Health-economic aspects of glaucoma screening].
    Hirneiss C; Niedermaier A; Kernt M; Kampik A; Neubauer AS
    Ophthalmologe; 2010 Feb; 107(2):143-9. PubMed ID: 19572134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of community screening for glaucoma in rural India: a decision analytical model.
    John D; Parikh R
    Public Health; 2018 Feb; 155():142-151. PubMed ID: 29407529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projected clinical outcomes of glaucoma screening in African American individuals.
    Ladapo JA; Kymes SM; Ladapo JA; Nwosu VC; Pasquale LR
    Arch Ophthalmol; 2012 Mar; 130(3):365-72. PubMed ID: 22411665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it worthwhile to conduct a randomized controlled trial of glaucoma screening in the United Kingdom?
    Burr J; Hernández R; Ramsay C; Prior M; Campbell S; Azuara-Blanco A; Campbell M; Francis J; Vale L
    J Health Serv Res Policy; 2014 Jan; 19(1):42-51. PubMed ID: 24088295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults.
    Sharafeldin N; Kawaguchi A; Sundaram A; Campbell S; Rudnisky C; Weis E; Tennant MTS; Damji KF
    Br J Ophthalmol; 2018 Nov; 102(11):1485-1491. PubMed ID: 29680803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for glaucoma in Canada: a systematic review of the literature.
    Einarson TR; Vicente C; Machado M; Covert D; Trope GE; Iskedjian M
    Can J Ophthalmol; 2006 Dec; 41(6):709-21. PubMed ID: 17224952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the socio-economic relevance of glaucoma].
    Grüb M; Rohrbach JM
    Klin Monbl Augenheilkd; 2006 Oct; 223(10):793-5. PubMed ID: 17063419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucoma screening. A cost-effectiveness analysis.
    Gottlieb LK; Schwartz B; Pauker SG
    Surv Ophthalmol; 1983; 28(3):206-26. PubMed ID: 6422576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early diagnosis of glaucoma].
    Hirneiss C; Neubauer AS; Kampik A
    MMW Fortschr Med; 2009 Jun; 151(24):34-5. PubMed ID: 19645199
    [No Abstract]   [Full Text] [Related]  

  • 11. Modelling the lifetime economic consequences of glaucoma in France.
    Philippe Nordmann J; Lafuma A; Berdeaux G
    J Med Econ; 2009 Mar; 12(1):9-16. PubMed ID: 19450060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for open angle glaucoma: systematic review of cost-effectiveness studies.
    Hernández R; Rabindranath K; Fraser C; Vale L; Blanco AA; Burr JM;
    J Glaucoma; 2008; 17(3):159-68. PubMed ID: 18414099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value-based medicine for glaucoma].
    Hirneiss C; Kampik A; Neubauer AS
    Ophthalmologe; 2010 Mar; 107(3):223-7. PubMed ID: 20182735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.
    Karnon J; Czoski-Murray C; Smith K; Brand C; Chakravarthy U; Davis S; Bansback N; Beverley C; Bird A; Harding S; Chisholm I; Yang YC
    Health Technol Assess; 2008 Jun; 12(27):iii-iv, ix-124. PubMed ID: 18513468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
    Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
    Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic aspects of the management of ocular hypertension.
    Worthen DM
    Surv Ophthalmol; 1980; 25(3):206-14. PubMed ID: 6781082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M
    Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of glaucoma interventions in Barbados and Ghana.
    Wittenborn JS; Rein DB
    Optom Vis Sci; 2011 Jan; 88(1):155-63. PubMed ID: 21076360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification and treatment of women with hyperglycaemia in pregnancy: an analysis of individual participant data, systematic reviews, meta-analyses and an economic evaluation.
    Farrar D; Simmonds M; Griffin S; Duarte A; Lawlor DA; Sculpher M; Fairley L; Golder S; Tuffnell D; Bland M; Dunne F; Whitelaw D; Wright J; Sheldon TA
    Health Technol Assess; 2016 Nov; 20(86):1-348. PubMed ID: 27917777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.